A literature review on the use of sibutramine, its efficacy and the risks in obesity therapy
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/34599 |
Resumo: | In the last decades, an increasing number of individuals considered obese has been observed, thus becoming a public health problem. Among the various types of treatments found to solve this problem, the drug sibutramine is found in the field of medicines. Research has shown different effects to this drug, especially cardiovascular ones. Therefore, the present study aimed to describe the therapeutic efficacy of sibutramine and present the advantages and risks of this drug to obese individuals. The study is based on a literature review, which was based on scientific works already published between the years 2017 to 2021 in Portuguese and English and that specifically deal with the proposed theme. Data collection took place in a database, such as the Virtual Health Library (VHL), Lilacs, Scielo, PubMed, and Google Scholar. Initially, it obtained 87 previously selected articles, the search resulted in 70 articles after using the inclusion and exclusion criteria; 20 articles remained for analysis, interpretation and discussion. In the results, it was evident that, from the studies found, sibutramine proved to be effective for the treatment of obesity, in the face of good medical and pharmaceutical follow-up, as well as good adherence by patients, associating the use of medication with healthy habits. and physical activity. |
id |
UNIFEI_121b9aa68bb0511e95b0a8013f8aed0a |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/34599 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
A literature review on the use of sibutramine, its efficacy and the risks in obesity therapyUna revisión de la literatura sobre el uso de sibutramina, su eficacia y los riesgos en la terapia de la obesidadUma revisão de literatura sobre o uso da sibutramina, sua eficácia e os riscos na terapêutica na obesidade SibutramineObesityEfficiencyTreatment.SibutraminaObesidadeEficáciaTratamento.SibutraminaObesidadEficienciaTratamiento.In the last decades, an increasing number of individuals considered obese has been observed, thus becoming a public health problem. Among the various types of treatments found to solve this problem, the drug sibutramine is found in the field of medicines. Research has shown different effects to this drug, especially cardiovascular ones. Therefore, the present study aimed to describe the therapeutic efficacy of sibutramine and present the advantages and risks of this drug to obese individuals. The study is based on a literature review, which was based on scientific works already published between the years 2017 to 2021 in Portuguese and English and that specifically deal with the proposed theme. Data collection took place in a database, such as the Virtual Health Library (VHL), Lilacs, Scielo, PubMed, and Google Scholar. Initially, it obtained 87 previously selected articles, the search resulted in 70 articles after using the inclusion and exclusion criteria; 20 articles remained for analysis, interpretation and discussion. In the results, it was evident that, from the studies found, sibutramine proved to be effective for the treatment of obesity, in the face of good medical and pharmaceutical follow-up, as well as good adherence by patients, associating the use of medication with healthy habits. and physical activity.En las últimas décadas se ha observado un aumento en el número de individuos considerados obesos, convirtiéndose así en un problema de salud pública. Entre los diversos tipos de tratamientos encontrados para solucionar este problema, el fármaco sibutramina se encuentra en el campo de los medicamentos. Las investigaciones han demostrado diferentes efectos de este fármaco, especialmente cardiovasculares. Por lo tanto, el presente estudio tuvo como objetivo describir la eficacia terapéutica de la sibutramina y presentar las ventajas y los riesgos de este fármaco para las personas obesas. El estudio se basa en una revisión de la literatura, que se basó en trabajos científicos ya publicados entre los años 2017 a 2021 en portugués e inglés y que tratan específicamente el tema propuesto. La recolección de datos ocurrió en una base de datos, como la Biblioteca Virtual en Salud (BVS), Lilacs, Scielo, PubMed y Google Scholar. Inicialmente obtuvo 87 artículos previamente seleccionados, la búsqueda resultó en 70 artículos luego de utilizar los criterios de inclusión y exclusión; Quedaron 20 artículos para análisis, interpretación y discusión. En los resultados, se evidenció que, a partir de los estudios encontrados, la sibutramina demostró ser eficaz para el tratamiento de la obesidad, ante un buen seguimiento médico y farmacéutico, así como una buena adherencia por parte de los pacientes, asociando el uso de medicamentos con hábitos saludables y actividad física.Nas últimas décadas, tem-se observado um número crescente de indivíduos considerados obesos, se tornando assim um problema de saúde pública. Dentre os vários tipos de tratamentos encontrados para resolver esse problema, encontra-se no âmbito dos medicamentos, o fármaco sibutramina. Pesquisas tem apontado efeitos diversos a esse fármaco, em especial os cardiovasculares. Diante disso, o presente estudo teve como objetivo descrever a eficácia terapêutica da sibutramina e apresentar as vantagens e riscos desse medicamento aos indivíduos obesos. O estudo é baseado em uma revisão sistemática de literatura, ao qual se fundamentou em trabalhos científicos já publicados entre os anos de 2017 a 2021 em língua portuguesa e inglesa e que tratem especificamente sobre a temática proposta. A coleta de dados se deu em base de banco de dados, tais como Biblioteca Virtual de Saúde (BVS), Lilacs, Scielo, PubMed, e Google Acadêmico. Inicialmente obteve 87 artigos previamente selecionados, a busca resultou em 70 artigos após utilização dos critérios de inclusão e exclusão; restaram 20 artigos para análise, interpretação e discussão. Nos resultados, ficou evidente que a pelos estudos encontrados, a sibutramina se mostrou eficaz para o tratamento da obesidade, diante de um bom acompanhamento médico e farmacêutico, bem como a boa adesão por parte dos pacientes associando o uso da medicação com hábitos saudáveis e atividade física. Research, Society and Development2022-09-13info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/3459910.33448/rsd-v11i12.34599Research, Society and Development; Vol. 11 No. 12; e253111234599Research, Society and Development; Vol. 11 Núm. 12; e253111234599Research, Society and Development; v. 11 n. 12; e2531112345992525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/34599/29048Copyright (c) 2022 Jessyane de Freitas Soares; Thiago Silvestre Magalhães ; Jéssyka Viana Valadares Franco; Felipe da Costa Freitas ; Nathacha Brito de Souza; Michelly Costa Silva; Bianca do Nascimento Luz; Ramyrys Pereira de Souza; Maysa Nathany Amorim Dourado; Érica Eugênio Lourenço Gontijohttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessSoares, Jessyane de Freitas Magalhães , Thiago Silvestre Franco, Jéssyka Viana Valadares Freitas , Felipe da Costa Souza, Nathacha Brito de Silva, Michelly Costa Luz, Bianca do Nascimento Souza, Ramyrys Pereira de Dourado, Maysa Nathany Amorim Gontijo, Érica Eugênio Lourenço 2022-09-26T11:56:08Zoai:ojs.pkp.sfu.ca:article/34599Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:49:50.164064Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
A literature review on the use of sibutramine, its efficacy and the risks in obesity therapy Una revisión de la literatura sobre el uso de sibutramina, su eficacia y los riesgos en la terapia de la obesidad Uma revisão de literatura sobre o uso da sibutramina, sua eficácia e os riscos na terapêutica na obesidade |
title |
A literature review on the use of sibutramine, its efficacy and the risks in obesity therapy |
spellingShingle |
A literature review on the use of sibutramine, its efficacy and the risks in obesity therapy Soares, Jessyane de Freitas Sibutramine Obesity Efficiency Treatment. Sibutramina Obesidade Eficácia Tratamento. Sibutramina Obesidad Eficiencia Tratamiento. |
title_short |
A literature review on the use of sibutramine, its efficacy and the risks in obesity therapy |
title_full |
A literature review on the use of sibutramine, its efficacy and the risks in obesity therapy |
title_fullStr |
A literature review on the use of sibutramine, its efficacy and the risks in obesity therapy |
title_full_unstemmed |
A literature review on the use of sibutramine, its efficacy and the risks in obesity therapy |
title_sort |
A literature review on the use of sibutramine, its efficacy and the risks in obesity therapy |
author |
Soares, Jessyane de Freitas |
author_facet |
Soares, Jessyane de Freitas Magalhães , Thiago Silvestre Franco, Jéssyka Viana Valadares Freitas , Felipe da Costa Souza, Nathacha Brito de Silva, Michelly Costa Luz, Bianca do Nascimento Souza, Ramyrys Pereira de Dourado, Maysa Nathany Amorim Gontijo, Érica Eugênio Lourenço |
author_role |
author |
author2 |
Magalhães , Thiago Silvestre Franco, Jéssyka Viana Valadares Freitas , Felipe da Costa Souza, Nathacha Brito de Silva, Michelly Costa Luz, Bianca do Nascimento Souza, Ramyrys Pereira de Dourado, Maysa Nathany Amorim Gontijo, Érica Eugênio Lourenço |
author2_role |
author author author author author author author author author |
dc.contributor.author.fl_str_mv |
Soares, Jessyane de Freitas Magalhães , Thiago Silvestre Franco, Jéssyka Viana Valadares Freitas , Felipe da Costa Souza, Nathacha Brito de Silva, Michelly Costa Luz, Bianca do Nascimento Souza, Ramyrys Pereira de Dourado, Maysa Nathany Amorim Gontijo, Érica Eugênio Lourenço |
dc.subject.por.fl_str_mv |
Sibutramine Obesity Efficiency Treatment. Sibutramina Obesidade Eficácia Tratamento. Sibutramina Obesidad Eficiencia Tratamiento. |
topic |
Sibutramine Obesity Efficiency Treatment. Sibutramina Obesidade Eficácia Tratamento. Sibutramina Obesidad Eficiencia Tratamiento. |
description |
In the last decades, an increasing number of individuals considered obese has been observed, thus becoming a public health problem. Among the various types of treatments found to solve this problem, the drug sibutramine is found in the field of medicines. Research has shown different effects to this drug, especially cardiovascular ones. Therefore, the present study aimed to describe the therapeutic efficacy of sibutramine and present the advantages and risks of this drug to obese individuals. The study is based on a literature review, which was based on scientific works already published between the years 2017 to 2021 in Portuguese and English and that specifically deal with the proposed theme. Data collection took place in a database, such as the Virtual Health Library (VHL), Lilacs, Scielo, PubMed, and Google Scholar. Initially, it obtained 87 previously selected articles, the search resulted in 70 articles after using the inclusion and exclusion criteria; 20 articles remained for analysis, interpretation and discussion. In the results, it was evident that, from the studies found, sibutramine proved to be effective for the treatment of obesity, in the face of good medical and pharmaceutical follow-up, as well as good adherence by patients, associating the use of medication with healthy habits. and physical activity. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-09-13 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/34599 10.33448/rsd-v11i12.34599 |
url |
https://rsdjournal.org/index.php/rsd/article/view/34599 |
identifier_str_mv |
10.33448/rsd-v11i12.34599 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/34599/29048 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 11 No. 12; e253111234599 Research, Society and Development; Vol. 11 Núm. 12; e253111234599 Research, Society and Development; v. 11 n. 12; e253111234599 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052821854486528 |